Skip to main content
VALITECPEPTIDES
Amino AxiomCompound CompareResearch Tools

Amino Axiom Compound Compare FAQ for Small-Molecule Research

On this page

What is the Amino Axiom compare tool?

Amino Axiom is a free research information and tracking platform that sits alongside the vendor network this brand belongs to. Its compare tool shows two compounds side by side, pairing structural attributes with a summary of the research literature on each. The tool is at https://www.aminoaxiom.com/compare.

This FAQ explains what a side-by-side view shows and how a researcher working with small molecules can read it. The focus is on interpreting descriptive information, not on any use of the material. Everything here is for research purposes only.

Why compare two small molecules side by side?

A single compound page answers questions about one compound. A comparison answers a different kind of question: how two compounds differ, and which of those differences affect how an experiment would be built. That is useful early in project planning, when a researcher is deciding which tools belong in a study.

Small molecules in a metabolic catalog are a good case. They are often grouped under one heading, yet they can belong to unrelated mechanistic classes. Placing two of them in adjacent columns makes the class difference obvious in a way that scrolling between two pages does not.

What attributes does a comparison show?

For a pair of small molecules the useful attributes fall into a few groups:

  • Identity. Name, chemical class, molecular formula and molecular weight.
  • Target. The enzyme, kinase or receptor family the literature associates with the compound.
  • Literature summary. What published work has examined, described in prose and without outcome claims.
  • Form. Whether an entry describes a free base, a salt or a cation.

The platform shows what its own entries contain, and a researcher should treat the view as a map pointing toward primary sources. It does not verify any material and says nothing about a particular lot.

How do AICAR, SLU-PP-332 and 5-Amino-1MQ compare?

The three compounds below are all small molecules in this brand's catalog, and the catalog values come from its own product metadata. They make a useful worked example because each belongs to a different mechanistic class.

Attribute AICAR SLU-PP-332 5-Amino-1MQ
Formula C9H14N4O5 C20H18F3N3O2 C10H11N2 (free base)
Molecular weight 258.23 g/mol 393.37 g/mol 159.21 g/mol (free base)
CAS number 2627-69-2 2155854-26-3 42464-96-0
Literature class Nucleotide analog studied for AMPK activation Synthetic ligand studied with the ERR family Inhibitor studied against NNMT

Reading across the rows, the molecular weights span roughly 159 to 393 g/mol, a spread of more than a factor of two. The mechanistic row matters more than the numbers, because it determines the experimental design.

What does the comparison mean for experimental design?

A kinase activator, a nuclear receptor ligand and an enzyme inhibitor need different controls and different readouts. An AMPK-related study would typically follow phosphorylation state of the kinase and its substrates. An ERR-related study would look at transcriptional readouts. An NNMT study can follow the enzyme's direct products, such as 1-methylnicotinamide.

Seeing the three in one table is a reminder that "metabolic research compound" is a browsing label and not a design category. The brand's articles on the AICAR AMPK research overview and the SLU-PP-332 ERR pathway overview describe two of these classes in more depth.

How should chemical form be handled in a comparison?

Chemical form is the most common source of a misleading comparison. A free base and its salt have different molecular weights, and any per-mole calculation changes with them. The 5-Amino-1MQ catalog entry above is labeled as a free base, and quinolinium compounds are charged species, so sources differ on whether they list a cation, a salt or a free-base description.

Before comparing weights, confirm that both columns describe the same kind of entry. Then match the form on the batch documentation to the form assumed in the calculation. The brand's article on interpreting mass spec data explains how the expected ion is derived from a stated molecular weight.

What can a comparison not tell a researcher?

Three limits are worth stating plainly:

  • It cannot rank compounds. A side-by-side view is descriptive, and suitability depends on the research question.
  • It cannot assess a lot. Purity and identity come from each batch's HPLC and mass-spectrometry records, covered in the article on research compound sourcing documentation.
  • It is a secondary source. Published primary literature remains the authority on what a compound has been shown to do in a given model.

Used within those limits, a comparison shortens the orientation phase of a project. Used beyond them, it becomes false confidence.

How should a researcher read the literature column?

The literature summary on a comparison is a pointer and not a verdict. It describes what published work has examined, such as the models used and the pathways measured, and it should be read as an index into primary papers. A useful habit is to note which model systems are named for each compound, because two compounds studied in entirely different systems cannot be compared on results even when they sit in adjacent columns.

It also helps to look for what is absent. A compound with a sparse literature column has a short research record, and a project built on it will lean more heavily on the investigating laboratory's own characterization. That is not a defect in the compound. It is information about how much prior work exists to compare against.

What are common mistakes when reading a comparison?

Four mistakes recur in practice:

  • Comparing molecular weights across different forms. A cation, a salt and a free base are different entries.
  • Treating similar names as similar mechanisms. Compounds with related-sounding names can act on unrelated targets.
  • Reading differences as rankings. A heavier or lighter molecule is not a better or worse one.
  • Skipping the date. A comparison viewed months ago may no longer match the platform.

Each is avoidable with a short checklist. Confirm form first, then target, then literature, and write down the date.

How should a comparison be recorded?

Platform content changes, so the date matters. A simple convention works well: note the two compounds, the attributes compared, the date viewed and a link to the page. When a project later asks why one tool was chosen over another, the note answers the question without anyone reconstructing it from memory.

Where do the other Amino Axiom features fit?

The compare tool is one feature of the platform. The compound library, price comparison, vendor directory, vendor status tracker and glossary are separate features, and this post covers only compare. Researchers who want to browse can start from the Amino Axiom homepage or go straight to the compare tool.

This article is provided for educational and research-information purposes only. The compounds discussed are research chemicals intended for laboratory research use only. They are not drugs, supplements, or food products, and are not intended to diagnose, treat, cure, or prevent any disease. Valitec Peptides does not supply products for human or animal use. Amino Axiom is an independent platform and this article makes no claims about its accuracy beyond what its comparison view visibly displays.

Reference

Common questions

The compare tool places two compounds side by side so their structural attributes and the research literature around them can be read together. It is an information view only. It does not recommend a compound, rank quality or describe any use of the material. For research purposes only.

Start with chemical class, molecular formula, molecular weight and the biological target named in the literature. Then check the form each entry describes, since a free base and a salt have different weights. Differences in target class matter most when planning which assays and controls a project needs.

No. A side-by-side view shows how two compounds differ, not which one suits a project. Suitability depends on the research question, the assay system and the documentation of the lot in hand. Treating a comparison as a ranking mistakes a descriptive tool for an evaluative one.

Comparing across target classes clarifies which controls and readouts each needs. A kinase activator, a nuclear receptor ligand and an enzyme inhibitor each call for a different assay panel. Seeing them together makes those differences explicit before an experiment is designed, not after.

Note the two compounds, the attributes compared, the date the page was viewed and a link to it. Platform content can change, so an undated note cannot be audited later. A dated record lets a project show what information shaped a design decision.